Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00539_DB00757_nanopub.RAYCR2eVqFYTzE6HvNKTFXqXCgkTWji_DzNQfQ6e3M7gY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00539_DB00757 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00539_DB00757 label "DDI between Toremifene and Dolasetron - Additive QTc-prolongation may occur, increasing the risk of serious ventricular arrhythmias. Consider alternate therapy. A thorough risk:benefit assessment is required prior to co-administration. [drugbank_resource:DB00539_DB00757]" assertion.
- drugbank_resource:DB00539_DB00757 identifier "drugbank_resource:DB00539_DB00757" assertion.
- drugbank_resource:DB00539_DB00757 title "DDI between Toremifene and Dolasetron - Additive QTc-prolongation may occur, increasing the risk of serious ventricular arrhythmias. Consider alternate therapy. A thorough risk:benefit assessment is required prior to co-administration." assertion.
- drugbank:DB00539 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00539_DB00757 assertion.
- drugbank:DB00757 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00539_DB00757 assertion.